Informed Consent

Informed Consent refers to the ethical and regulatory process through which clinical trial participants voluntarily agree to participate after receiving clear information regarding study purpose, procedures, potential risks, benefits, alternatives, and their rights. This process ensures participants understand what participation involves and confirms that their decision is free from coercion. Informed consent is an ongoing communication process maintained throughout trial participation.

The biopharmaceutical industry implements informed consent as a fundamental requirement under Good Clinical Practice and ethical review frameworks. Consent forms must be written in understandable language, approved by ethics committees, and updated when new safety information emerges. Investigators ensure participants have opportunities to ask questions and withdraw at any time without penalty. Special protections apply for vulnerable populations including children and cognitively impaired individuals. Digital consent platforms increasingly support remote trials. Regulatory inspections frequently evaluate informed consent practices, as failures can invalidate trial data and raise serious ethical concerns.